Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 105501-105550 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04043195
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Aug 14, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04033510
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)
N/A
Active, not recruiting
600 participants
Started: Aug 14, 2019 · Completed: Jan 30, 2027
6 conditions
2 sponsors
1 location
NCT03841058
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
PHASE2
Recruiting
96 participants
Started: Aug 14, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT03945747
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
N/A
Active, not recruiting
50 participants
Started: Aug 14, 2019 · Completed: Aug 1, 2026
8 conditions
4 sponsors
1 location
NCT04280536
Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)
PHASE1/PHASE2
Active, not recruiting
86 participants
Started: Aug 14, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03321370
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
N/A
Recruiting
10 participants
Started: Aug 14, 2019 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT03531645
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
PHASE2
Active, not recruiting
18 participants
Started: Aug 13, 2019 · Completed: Sep 30, 2027
1 condition
3 sponsors
1 location
NCT03961568
Cenobamate Open-Label Extension Study for YKP3089C025
PHASE3
Enrolling by invitation
145 participants
Started: Aug 13, 2019 · Completed: Aug 31, 2026
1 condition
1 sponsor
45 locations
NCT04044768
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
PHASE2
Active, not recruiting
52 participants
Started: Aug 13, 2019 · Completed: Apr 1, 2038
2 conditions
1 sponsor
26 locations
NCT03946878
Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
PHASE2
Active, not recruiting
32 participants
Started: Aug 13, 2019 · Completed: Feb 8, 2026
9 conditions
2 sponsors
1 location
NCT04077723
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2
Recruiting
498 participants
Started: Aug 13, 2019 · Completed: Mar 31, 2027
1 condition
1 sponsor
39 locations
NCT05267496
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
NA
Active, not recruiting
72 participants
Started: Aug 13, 2019 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04047706
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PHASE1
Active, not recruiting
18 participants
Started: Aug 13, 2019 · Completed: Jun 1, 2027
1 condition
2 sponsors
1 location
NCT03713125
Executive Function in Early Childhood
NA
Recruiting
260 participants
Started: Aug 13, 2019 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT06330987
Fetal Autonomic Nervous sysTem Evaluation
N/A
Recruiting
186 participants
Started: Aug 13, 2019 · Completed: Dec 28, 2025
8 conditions
2 sponsors
1 location
NCT04009499
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
PHASE3
Active, not recruiting
1,131 participants
Started: Aug 13, 2019 · Completed: May 25, 2026
1 condition
1 sponsor
138 locations
NCT04071457
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
PHASE3
Active, not recruiting
1,100 participants
Started: Aug 13, 2019 · Completed: Jul 1, 2040
1 condition
3 sponsors
842 locations
NCT03870854
Paced Electrogram Feature Analysis (PEFA) for Ablation Targeting in Ischaemic Ventricular Tachycardia
NA
Recruiting
40 participants
Started: Aug 13, 2019 · Completed: Sep 30, 2025
1 condition
1 sponsor
3 locations
NCT04031508
Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH
PHASE2
Enrolling by invitation
40 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
NCT04734158
CORNEAL EPITHELIAL MAPPING IN DIABETICS
N/A
Active, not recruiting
153 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03900221
French Registry for Monitoring Pregnancies for Multiple Sclerosis
N/A
Recruiting
1,500 participants
Started: Aug 12, 2019 · Completed: Aug 12, 2036
4 conditions
1 sponsor
46 locations
NCT03929549
Preliminary Evaluation of a RCMP to Predict Failure of Maxillomandibular Advancement Surgery for OSA
NA
Recruiting
20 participants
Started: Aug 12, 2019 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT04036435
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
PHASE3
Active, not recruiting
1,466 participants
Started: Aug 12, 2019 · Completed: Jul 26, 2026
1 condition
1 sponsor
302 locations
NCT04035811
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
N/A
Active, not recruiting
271 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
32 locations
NCT04047784
Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients
NA
Enrolling by invitation
60 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT04035005
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
PHASE3
Active, not recruiting
1,013 participants
Started: Aug 12, 2019 · Completed: Jan 19, 2028
1 condition
1 sponsor
159 locations
NCT03975634
Transcutaneous Spinal Stimulation: Safety and Feasibility for Trunk Control in Children With Spinal Cord Injury
NA
Active, not recruiting
9 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT04064060
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
PHASE3
Recruiting
665 participants
Started: Aug 12, 2019 · Completed: May 12, 2028
3 conditions
1 sponsor
143 locations
NCT05773222
Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient
N/A
Active, not recruiting
2,500 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03735420
Xanthohumol Metabolism and Signature
PHASE1
Active, not recruiting
30 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
PHASE1/PHASE2
Recruiting
345 participants
Started: Aug 12, 2019 · Completed: Nov 15, 2027
2 conditions
1 sponsor
17 locations
NCT04196452
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
N/A
Active, not recruiting
10 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2034
1 condition
1 sponsor
0 locations
NCT03706482
Boost Brittle Bones Before Birth
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Aug 12, 2019 · Completed: Apr 30, 2030
1 condition
8 sponsors
1 location
NCT03742193
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
PHASE2
Active, not recruiting
43 participants
Started: Aug 11, 2019 · Completed: Dec 30, 2023
3 conditions
1 sponsor
1 location
NCT05025150
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
N/A
Recruiting
1,020 participants
Started: Aug 11, 2019 · Completed: Dec 8, 2025
2 conditions
1 sponsor
1 location
NCT04068597
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
PHASE1/PHASE2
Recruiting
250 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2027
6 conditions
1 sponsor
23 locations
NCT04037358
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
PHASE2
Active, not recruiting
64 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2028
1 condition
3 sponsors
1 location
NCT04352816
Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy
NA
Active, not recruiting
103 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04083963
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
PHASE2
Active, not recruiting
13 participants
Started: Aug 9, 2019 · Completed: Sep 27, 2026
1 condition
1 sponsor
1 location
NCT03980717
Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH
NA
Recruiting
80 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2030
1 condition
2 sponsors
1 location
NCT04001829
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
PHASE2
Active, not recruiting
249 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2027
21 conditions
2 sponsors
485 locations
NCT04117230
CARDSUP - SWISS Circulatory Support Registry
N/A
Recruiting
1,500 participants
Started: Aug 9, 2019 · Completed: Aug 31, 2034
1 condition
1 sponsor
5 locations
NCT03899155
Pan Tumor Rollover Study
PHASE2
Recruiting
1,500 participants
Started: Aug 9, 2019 · Completed: Aug 25, 2029
1 condition
5 sponsors
396 locations
NCT03890861
"Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
NA
Recruiting
125 participants
Started: Aug 9, 2019 · Completed: Nov 30, 2026
1 condition
2 sponsors
1 location
NCT03584152
Postoperative Pain Management in Rhinoplasty
PHASE2
Active, not recruiting
130 participants
Started: Aug 9, 2019 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT04578678
Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease
N/A
Active, not recruiting
105 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2026
2 conditions
2 sponsors
4 locations
NCT04053439
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
N/A
Recruiting
188 participants
Started: Aug 8, 2019 · Completed: Sep 30, 2026
2 conditions
3 sponsors
1 location
NCT04130659
Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone
NA
Recruiting
110 participants
Started: Aug 8, 2019 · Completed: Jan 31, 2025
1 condition
2 sponsors
5 locations
NCT06400251
Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)
PHASE2
Active, not recruiting
35 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04106856
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
PHASE1
Active, not recruiting
22 participants
Started: Aug 8, 2019 · Completed: Aug 8, 2026
7 conditions
2 sponsors
1 location
Previous
1
More pages
2108
2109
2110
2111
2112
2113
2114
More pages
2369
Next